Matches in SemOpenAlex for { <https://semopenalex.org/work/W137336246> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W137336246 endingPage "40" @default.
- W137336246 startingPage "229" @default.
- W137336246 abstract "With the ever-increasing use of pharmaceuticals and the relatively high risk of developing drug allergies, particularly for patients in hospitals and for ambulatory patients with a history of drug allergy, the need to develop in vitro assays for drug allergy is great. In the early 1970's a mast cell technique was developed for diagnosis of drug allergies. A PRIST inhibition assay has also recently been developed to detect IgE antibodies to drug allergens. This test has also been referred to as the Total IgE Inhibition Test by Specific Drug Allergen, and is a variant of the in vitro RAST Test. In vitro mast cell and IgE inhibition tests are applied for identification of drug and chemical allergens and for their cautious clinical trial to prevent future drug and chemical reactions. Over the last eight years, over 1,300 patients were examined utilizing the mast cell technique. Over 100 drugs were tested, with penicillin, barbiturates, caine derivatives and sulfonamides most frequently employed. Of 270 patients with well-defined drug reactions, 190 (70 per cent) gave a positive response to the mast cell test. Eighty-five per cent of sera tested with Type I reactions gave a mast cell response. Of these, a group of 30 patients was studied with PRIST inhibition as well. Procedures for comparative testing of necessary drugs and/or chemicals in cases of high anaphylaxis risk of reaction in the clinical setting, hospital or office are included in the study as well as individual case reports. Mast cell assay coupled with IgE inhibition has been successfully used to diagnose drug and chemical allergic reactions. The incidence of positivity is high when the offending drug causes a Type I allergic reaction. The cases reported indicate that both the Mast Cell and the PRIST inhibition assays are useful for diagnosing and setting the clinical treatment and clinical course of the patient. The mast cell assay would be potentially employed for patient use in hospitals where the incidence of drug allergy is highest and for occupational health in the chemical industry. The greatest potential would be in outpatient care applied to patients with multiple drug allergies in the selection of safe drugs (test negative by both methods, and other clinical studies) for future drug usage." @default.
- W137336246 created "2016-06-24" @default.
- W137336246 creator A5036605049 @default.
- W137336246 creator A5069033570 @default.
- W137336246 date "1982-05-01" @default.
- W137336246 modified "2023-09-23" @default.
- W137336246 title "The diagnosis of drug allergies. Utilizing in vitro mast cell test and IgE inhibition test." @default.
- W137336246 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6816053" @default.
- W137336246 hasPublicationYear "1982" @default.
- W137336246 type Work @default.
- W137336246 sameAs 137336246 @default.
- W137336246 citedByCount "6" @default.
- W137336246 crossrefType "journal-article" @default.
- W137336246 hasAuthorship W137336246A5036605049 @default.
- W137336246 hasAuthorship W137336246A5069033570 @default.
- W137336246 hasConcept C141105273 @default.
- W137336246 hasConcept C159654299 @default.
- W137336246 hasConcept C203014093 @default.
- W137336246 hasConcept C207480886 @default.
- W137336246 hasConcept C2775933838 @default.
- W137336246 hasConcept C2779060952 @default.
- W137336246 hasConcept C2779726688 @default.
- W137336246 hasConcept C2780035454 @default.
- W137336246 hasConcept C2780510475 @default.
- W137336246 hasConcept C71924100 @default.
- W137336246 hasConcept C98274493 @default.
- W137336246 hasConceptScore W137336246C141105273 @default.
- W137336246 hasConceptScore W137336246C159654299 @default.
- W137336246 hasConceptScore W137336246C203014093 @default.
- W137336246 hasConceptScore W137336246C207480886 @default.
- W137336246 hasConceptScore W137336246C2775933838 @default.
- W137336246 hasConceptScore W137336246C2779060952 @default.
- W137336246 hasConceptScore W137336246C2779726688 @default.
- W137336246 hasConceptScore W137336246C2780035454 @default.
- W137336246 hasConceptScore W137336246C2780510475 @default.
- W137336246 hasConceptScore W137336246C71924100 @default.
- W137336246 hasConceptScore W137336246C98274493 @default.
- W137336246 hasIssue "3" @default.
- W137336246 hasLocation W1373362461 @default.
- W137336246 hasOpenAccess W137336246 @default.
- W137336246 hasPrimaryLocation W1373362461 @default.
- W137336246 hasRelatedWork W137336246 @default.
- W137336246 hasRelatedWork W183119610 @default.
- W137336246 hasRelatedWork W2018681876 @default.
- W137336246 hasRelatedWork W2025371411 @default.
- W137336246 hasRelatedWork W2093476398 @default.
- W137336246 hasRelatedWork W2154955046 @default.
- W137336246 hasRelatedWork W2396310151 @default.
- W137336246 hasRelatedWork W2738566540 @default.
- W137336246 hasRelatedWork W2771526014 @default.
- W137336246 hasRelatedWork W3191587412 @default.
- W137336246 hasVolume "10" @default.
- W137336246 isParatext "false" @default.
- W137336246 isRetracted "false" @default.
- W137336246 magId "137336246" @default.
- W137336246 workType "article" @default.